Cellergy Therapeutics
PrivateLast Round
Seed
Oct 14, 2024
Total Funding Raised
$1.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellergy Therapeutics operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in October 2024.
Cellergy Therapeutics is a biotechnology company that is developing mitochondrial transplantation therapies to treat degenerative and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellergy Therapeutics Comparables
Compare Cellergy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| cellvie | 85% | |
| Minovia Therapeutics | 84% | |
| PAEAN Biotechnology | 82% |
For institutional investors. Book with your work email.
Cellergy Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 348% MoM, reaching 1K.
- Jun 26, 2026
Grew 33% QoQ from 12 to 16 employees.
For institutional investors. Book with your work email.
Cellergy Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellergy Therapeutics's valuation, stock price, and market status.
Is Cellergy Therapeutics a public or private company?
Cellergy Therapeutics is a private company.
What is the current stock price of Cellergy Therapeutics?
Cellergy Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cellergy Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellergy Therapeutics worth (valuation)?
Valuation information for Cellergy Therapeutics is not publicly available.
Can I buy Cellergy Therapeutics stock?
Cellergy Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellergy Therapeutics's last funding round?
Cellergy Therapeutics's most recent funding round was Seed on October 14, 2024.
Who are the main investors in Cellergy Therapeutics?
Investor information for Cellergy Therapeutics is not publicly disclosed.
Will Cellergy Therapeutics IPO soon?
No public IPO plans have been announced for Cellergy Therapeutics.
How can I track Cellergy Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cellergy Therapeutics's shares on secondary markets.